Skip to contentI
Inspire Medical Systems, Inc.
I
INSPInspire Medical Systems, Inc. Q3 2024 · 10-Q
Revenue$203.19M$203.19M+32.5% vs Q3 2023 Net Income$18.50M$18.50MN/M vs Q3 2023 EPS Diluted$0.60$0.60N/M vs Q3 2023 Gross Profit$170,793,000+32.5% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Inspire Medical Systems, Inc. · CIK 1609550 · Engraved from SEC EDGAR
Operating Cash Flowderived$52,283,000+1,337.1% Free Cash Flowderived$44,276,000N/M Margins · derivedGross margin84.1%−0.0 pt vs Q3 2023
Operating margin7.0%+15.8 pt vs Q3 2023
Net margin9.1%+14.7 pt vs Q3 2023
ended Sep 30, 2024 · filed Nov 4, 2024 · 35 d after period end